Trial Profile
Efficacy of rituximab in patients with secondary-progressive multiple sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Sep 2014
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 29 Sep 2014 New trial record